Patents by Inventor Shreyans Kumar Jain

Shreyans Kumar Jain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Indolylkojyl methane analogues, process of preparation thereof and use as inhibitor of cancer cells invasion and metastasis
    Patent number: 11180486
    Abstract: The present invention discloses novel indolylkojyl compounds of formula 1 The invention also provides a one pot, green chemistry method for preparation of indolylkojyl compounds. The compounds of the present invention are selectively toxic towards human breast cancer cells and inhibit tumor growth as well as lung metastasis. The compounds also potentiate the effect of anticancer drugs.
    Type: Grant
    Filed: February 5, 2018
    Date of Patent: November 23, 2021
    Assignee: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Debaraj Mukherjee, Anindya Goswami, Deepak Sharma, Debasis Nayak, Shreyans Kumar Jain
  • INDOLYLKOJYL METHANE ANALOGUES, PROCESS OF PREPARATION THEREOF AND USE AS INHIBITOR OF CANCER CELLS INVASION AND METASTASIS
    Publication number: 20200115365
    Abstract: The present invention discloses novel indolylkojyl compounds of formula 1 The invention also provides a one pot, green chemistry method for preparation of indolylkojyl com-pounds. The compounds of the present invention are selectively toxic towards human breast cancer cells and inhibit tumor growth as well as lung metastasis. The compounds also potentiate the effect of anticancer drugs.
    Type: Application
    Filed: February 5, 2018
    Publication date: April 16, 2020
    Inventors: Debaraj MUKHERJEE, Anindya GOSWAMI, Deepak SHARMA, Debasis NAYAK, Shreyans Kumar JAIN
  • Chromone alkaloid dysoline for the treatment of cancer and inflammatory disorders
    Patent number: 9776989
    Abstract: The present invention relates to novel chromone alkaloid of formula 1 isolated from the plant Dysoxylum binectariferum. The compound 5,7-dihydroxy-6-(3-hydroxy-1-methylpiperidin-4-yl)-2-methyl-4H-chromen-4-one, is found to be a potential inhibitor of cell growth and proliferation and also inhibits production of pro-inflammatory cytokines. The formulations of this particular compound can be used for treatment of cancer and inflammation.
    Type: Grant
    Filed: March 31, 2014
    Date of Patent: October 3, 2017
    Assignee: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Ram Asrey Vishwakarma, Shreyans Kumar Jain, Sandip Bibishan Bharate, Abid Hamid Dar, Anamika Khajuria, Samdarshi Meena, Sunil Kumar Bhola, Asif Khurshid Qazi, Aashiq Hussain, Tabasum Sidi, Shaanker Ramanan Uma, Gudasalamani Ravikanth, Ramesh Vasudeva, Kumara Patel Mohana, Kotiganahalli Narayanagowda Ganeshaiah
  • Tetrahydro-2H-pyrano[3,2-C]isochromene-6-ones and analogs for the treatment of inflammatory disorders
    Patent number: 9777014
    Abstract: The present invention relates to 2,3,4,4a-tetrahydro-3,4,8,10-tetrahydroxy-2-(hydroxymethyl)-9-methoxypyrano[3,2-c]isochromen-6(10bH)-one analogs of the Formula I, wherein, R, R? and R? are as herein described. In addition, the invention relates to methods of using compounds for treating or preventing various inflammatory disorders such as rheumatoid arthritis, inflammatory bowel disease, psoriasis, asthma and chronic obstructive pulmonary disorder.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: October 3, 2017
    Assignee: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Shreyans Kumar Jain, Tabasum Sidiq, Samdarshi Meena, Anamika Khajuria, Ram Asrey Vishwakarma, Sandip Bibishan Bharate
  • TETRAHYDRO-2H-PYRANO[3,2-C]ISOCHROMENE-6-ONES AND ANALOGS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
    Publication number: 20160122360
    Abstract: The present invention relates to 2,3,4,4a-tetrahydro-3,4,8,10-tetrahydroxy-2-(hydroxymethyl)-9-methoxypyrano[3,2-c]isochromen-6(10bH)-one analogs of the Formula I, wherein, R, R? and R? are as herein described. In addition, the invention relates to methods of using compounds for treating or preventing various inflammatory disorders such as rheumatoid arthritis, inflammatory bowel disease, psoriasis, asthma and chronic obstructive pulmonary disorder.
    Type: Application
    Filed: November 1, 2013
    Publication date: May 5, 2016
    Applicant: Council of Scientific & Industrial Research
    Inventors: Shreyans Kumar Jain, Tabasum Sidiq, Samdarshi Meena, Anamika Khajuria, Ram Asrey Vishwakarma, Sandip Bibishan Bharate
  • NOVEL CHROMONE ALKALOID DYSOLINE FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISORDERS
    Publication number: 20160046611
    Abstract: The present invention relates to novel chromone alkaloid of formula 1 isolated from the plant Dysoxylum binectariferum. The compound 5,7-dihydroxy-6-(3-hydroxy-1-methylpiperidin-4-yl)-2-methyl-4H-chromen-4-one, is found to be a potential inhibitor of cell growth and proliferation and also inhibits production of pro-inflammatory cytokines. The formulations of this particular compound can be used for treatment of cancer and inflammation.
    Type: Application
    Filed: March 31, 2014
    Publication date: February 18, 2016
    Inventors: Ram Asrey Vishwakarma, Shreyans Kumar Jain, Sandip Bibishan Bharate, Abid Hamid Dar, Anamika Khajuria, Samdarshi Meena, Sunil Kumar Bhola, Asif Khurshid Qazi, Aashiq Hussain, Tabasum Sidi, Shaanker Ramanan Uma, Gudasalamani Ravikanth, Ramesh Vasudeva, Kumara Patel Mohana, Kotiganahalli Narayanagowda Ganeshaiah